NICE Endorses Pegzilarginase for Treating Argin...

By HEOR Staff Writer

February 17, 2026

NICE Backs Pegzilarginase for Arginase Deficiency The National Institute for Health and Care Excellence (NICE) final draft guidance recommends pegzilarginase arginase deficiency trea...
Advancing Cancer Screening in Slovenia: A Pathway to Equitable Care
Robotic Surgery Portugal: A Landmark Achievement at ULS Viseu Dão-Lafões
Strategic Vision and Infarmed 2026 Priorities for Regulatory Reform
AstraZeneca Financial Results: Strong Revenue Growth and Pipeline Expansion i...
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
European Pharma Competitiveness: A Cornerstone for EU Economic Resilience
National HealthTech Access: Transforming NHS Adoption and Equity
Tislelizumab NSCLC Inclusion Recommended for Dutch Health Package
Healthcare Innovation Trends Shaping the Future: Insights from the J.P. Morga...
Novo Nordisk Growth Projections: Insights on 2025 Performance and 2026 Outlook
AI Healthcare Costs: Navigating Financial Hurdles in Technology Integration
Ozempic Public Funding Approval in Portugal: Key Insights and Implications